Aurinia Pharmaceuticals (AUP) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Aurinia Pharmaceuticals: Strong Q3 Performance and Promising Outlook Justify Buy RatingNovember 9, 2024 | markets.businessinsider.comAurinia Pharmaceuticals Reports Strong Growth and Strategic RestructuringNovember 9, 2024 | markets.businessinsider.comAurinia slashes workforce by 45% to focus on lupus and autoimmune assetsNovember 9, 2024 | msn.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | msn.comAurinia Pharmaceuticals: Strong Growth Prospects Bolstered by Lupkynis Sales and Promising PipelineNovember 7, 2024 | markets.businessinsider.comAurinia Pharmaceuticals reports Q3 EPS 10c, consensus 1cNovember 7, 2024 | markets.businessinsider.comAurinia Pharmaceuticals Reports Strong Q3 Growth and RestructuringNovember 7, 2024 | markets.businessinsider.comAurinia Pharmaceuticals (NASDAQ:AUPH) Stock, Guidance And ForecastOctober 18, 2024 | benzinga.comBuy Rating Affirmed for Aurinia Pharmaceuticals on AUR200’s Clinical and Financial PromiseSeptember 7, 2024 | markets.businessinsider.comAurinia doses first subject in Phase Ia trial of AUR200 for autoimmune diseasesSeptember 6, 2024 | msn.comAurinia Pharmaceuticals Share Price (AUPH.US)August 28, 2024 | lse.co.ukAnalysts Have Conflicting Sentiments on These Healthcare Companies: uniQure (QURE), Aurinia Pharmaceuticals (AUPH) and Vertex Pharmaceuticals (VRTX)August 2, 2024 | markets.businessinsider.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call TranscriptMay 3, 2024 | msn.comAurinia Pharma: A Welcome Change To The Thesis (Rating Upgrade)May 3, 2024 | seekingalpha.comAUPH Stock Earnings: Aurinia Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), Aurinia Pharmaceuticals (AUPH) and 908 Devices (MASS)May 2, 2024 | markets.businessinsider.comAurinia: Q1 Earnings SnapshotMay 2, 2024 | washingtonpost.comAurinia Pharmaceuticals Inc.February 29, 2024 | barrons.comAurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock BuybackFebruary 15, 2024 | msn.comExclusive-Kidney drug developer Aurinia fails to clinch a sale, sources sayFebruary 15, 2024 | msn.comAurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06MFebruary 15, 2024 | msn.comAurinia drops after Q4 miss; strategic review failsFebruary 15, 2024 | msn.comAurinia to stop development of immunotherapies after strategic reviewFebruary 15, 2024 | reuters.comExclusive: Kidney drug developer Aurinia fails to clinch a sale, sources sayFebruary 15, 2024 | reuters.comAurinia Pharma Q4 2023 Earnings PreviewFebruary 14, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Arrowhead Pharmaceuticals (ARWR)February 8, 2024 | markets.businessinsider.comAurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseFebruary 8, 2024 | msn.comAurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in JapanNovember 13, 2023 | benzinga.comAurinia Says Its Partner Otsuka Filed NDA For Voclosporin In JapanNovember 13, 2023 | markets.businessinsider.comStrong 3Q Performance and Growing Lupkynis Sales Bolster Aurinia Pharmaceuticals’ Buy Rating: An In-depth Analysis by David Martin, PhDNovember 6, 2023 | markets.businessinsider.comAurinia Pharmaceuticals Inc. (AUPH) Q3 2023 Earnings Call TranscriptNovember 2, 2023 | seekingalpha.comAurinia Pharmaceuticals: Reassessing As It Gains TractionSeptember 27, 2023 | msn.comAurinia Pharmaceuticals Inc. (AUPH) Q2 2023 Earnings Call TranscriptAugust 3, 2023 | seekingalpha.comAurinia Pharmaceuticals Stock Returns To A Rising Relative StrengthJuly 18, 2023 | msn.comAurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder ValueJune 29, 2023 | benzinga.comAurinia Pharmaceuticals: Still In The Game With Lupkynis SalesJune 16, 2023 | msn.comAurinia Pharmaceuticals Earnings Perspective: Return On Capital EmployedMay 18, 2023 | msn.comMKT Capital Thanks Fellow Shareholders for Their Strong Support at Aurinia's 2023 Annual MeetingMay 17, 2023 | technews.tmcnet.comNews Flash: Analysts Just Made A Sizeable Upgrade To Their Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ForecastsMay 9, 2023 | finance.yahoo.comBloom Burton Remains a Buy on Aurinia Pharmaceuticals (AUPH)May 6, 2023 | markets.businessinsider.comMKT Capital Issues Statement Regarding Aurinia's Disappointing First Quarter 2023 Financial ResultsMay 5, 2023 | technews.tmcnet.comAurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational ResultsMay 4, 2023 | finance.yahoo.comAurinia Pharma gains after Q1 beat and guidance raiseMay 4, 2023 | msn.comAurinia Pharmaceuticals: Q1 Earnings InsightsMay 4, 2023 | msn.comISS Recommends Aurinia Shareholders Vote Against the Company’s Named Executive Officers’ CompensationMay 3, 2023 | theglobeandmail.comToni Braxton and Aurinia Want People with Lupus Nephritis to Get Uncomfortable to Protect their KidneysApril 25, 2023 | finance.yahoo.comMKT Capital Issues Letter to Aurinia Shareholders Announcing its Intention to Withhold Support for Three Directors at 2023 Annual MeetingApril 25, 2023 | marketwatch.comWhy Aurinia Pharmaceuticals Stock Is Glowing Green TodayApril 11, 2023 | msn.comWe Think Aurinia Pharmaceuticals (NASDAQ:AUPH) Can Easily Afford To Drive Business GrowthApril 4, 2023 | finance.yahoo.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call TranscriptMarch 9, 2023 | insidermonkey.com Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUP and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. AUP Media Mentions By Week AUP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUP News Sentiment▼0.000.60▲Average Computer and Technology News Sentiment AUP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUP Articles This Week▼00▲AUP Articles Average Week Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bausch Health Companies News Premium Brands News Tilray Brands News Cronos Group News Solaris Resources News Aimia News Andean Precious Metals News Fennec Pharmaceuticals News Cardiol Therapeutics News Gear Energy News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:AUP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurinia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurinia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
